Microsoft word - april 2009 detailed formulary.doc
2009 Detailed Formulary April 2009 INTRODUCTION This Member Formulary is a useful aid to understanding your drug benefit program. The formulary is a list of drugs reviewed and approved by an independent committee of physicians and pharmacists. The formulary includes drugs that are commonly prescribed by physicians, clinically useful, and cost-effective.
Bring this Member Formulary to your doctor appointments. Your doctor can review the formulary and determine if a drug listed isappropriate for you. When you have a prescription filled, your copayment will be at one of three levels or "tiers." Tier 1 and tier 2 drugswill be the lower copayments. However, a tier 1 or tier 2 drug may not always be available or the best choice for your medical condition. Tier 1 (lowest copayment) includes only generic versions of brand-name drugs. Generic drugs are noted in lowercase type. A brand- name drug that is bolded indicates that a generic is available. All generic drugs, whether listed in this formulary or not, are the lowest copayment. Tier 2 (intermediate copayment) includes selected brand-name drugs. Brand-name drugs are noted in all capital letters. Tier 3 (highest copayment) includes all brand-name drugs not listed in tier 2 and includes all brands not listed in this formulary. Brand-name drugs are shown in capital letters. Those with generic versions available are identified with a bolded brand name. Generic versions of brand-name drugs are always in tier 1 (lowest copayment.)
The drug names listed here are the registered and/or unregistered trademarks of third-party pharmaceutical companies unrelated toand unaffiliated with Script Care. These trademarked brand names are included here for informational purposes only and are notintended to imply or suggest any affiliation between Script Care and such third-party pharmaceutical companies. LEARNING MORE ABOUT GENERIC DRUGS One way you can reduce your out-of-pocket cost is by requesting a generic drug. A generic drug is a copy of the original brand-name drug, whether prescription or over-the-counter. Generic drugs are usually priced lower than their brand-name equivalents. Generic drugs are: •
Approved by the U.S. Food and Drug Administration for safety and effectiveness, and are manufactured under the same strictstandards which apply to brand-name drugs.
Tested in humans to assure the generic is absorbed in the bloodstream in a similar manner as the brand-name drug. Generics maybe different from the brand in size, color, and inactive ingredients, but this does not alter the effectiveness or the ability to beabsorbed just like the brand-name drug.
Manufactured in the same strength and dosage form as the brand-name drug. When a generic drug is substituted for a brand-name drug, you can expect the generic to produce the same clinical effect and safety profile as the brand-name drug. HELPFUL HINTS FOR TAKING DRUGS PROPERLY •
Consult your pharmacist when you have questions about prescription and over-the-counter drugs.
Take your medication exactly as prescribed.
Store your medication at room temperature unless advised differently on the label.
Display the telephone number of your local Poison Control Center on your phone.
Keep an up-to-date list of your prescription and over-the-counter drugs, including the dosage schedule and the name of theprescribing physician, in your purse or wallet. Every time you have an appointment, show the list to your doctor. IMPORTANT Your benefit coverage may not be limited to this list. There may be drugs listed here that are not covered by your specific plan. Some strengths/dosage forms of drugs listed may not be on the formulary. Using this list is voluntary. This list is subject to change at any time. Refer to your benefit materials or call your prescription benefit member services telephone number for specific coverage information.
Only the dosage forms/strengths of the brand-name product noted are on the Member Formulary
Only the brand-name product noted is on the Member Formulary Boldface
Indicates generic availability; boldface may not apply to every strength or dosage form under the listed generic name
delayed-rel Delayed-release (also known as enteric-coated), refer to the reference brand listed for clarification ext-rel
Extended-release (also known as sustained-release), refer to the reference brand listed for clarification
ANALGESICS
Practice guidelines of pain management are
colchicine tabs
available at: http://www.asahq.org probenecid ZYLOPRIM diflunisal etodolac NARCOTIC ANALGESICS indomethacin DILAUDID nabumetone
Management (includes WHO analgesic ladder)
DURAGESIC salsalate
are available at: http://www.asahq.org MS CONTIN http://www.nccn.org/professionals
Opioid guidelines in the management of chronic
PERCOCET CLINORIL ROXICODONE http://www.asipp.org/Guidelines.htm INDOCIN SR NON-NARCOTIC ANALGESICS FIORICET MAXIDONE FIORINAL NAPROSYN VOLTAREN TYLENOL w/CODEINE VICODIN ES VISCOSUPPLEMENTS COX-2 INHIBITORS NARCOTIC ANALGESICS, CII morphine morphine supp oxycodone soln ANTI-INFECTIVES Hepatitis: CDC recommendations on the Sulfonamides http://www.cdc.gov/ncidod/diseases/hepatiti s/index.htm Second Generation
hepatitis by the American Association for the
Tetracyclines http://www.aasld.org tetracycline HIV/AIDS: Guidelines for the treatment of HIV Third Generation
patients by the U.S. Department of Health and
http://www.aidsinfo.nih.gov PERIOSTAT Infective Endocarditis: American Heart VIBRAMYCIN
Association recommendations for theprevention of bacterial endocarditis are
Erythromycins/Macrolides ANTIFUNGALS
available at: http://www.americanheart.org Influenza: Recommendations of the Advisory erythromycin delayed-rel erythromycin stearate http://www.cdc.gov/ncidod/diseases/flu/fluvi DIFLUCAN BIAXIN XL LAMISIL # International Travel: CDC recommendations
for international travel are available at:
PEDIAZOLE MYCOSTATIN http://www.cdc.gov/travel ZITHROMAX Sexually Transmitted Diseases: CDC SPORANOX
Sexually Transmitted Diseases Guidelines are
Fluoroquinolones ANTIMALARIALS http://www.cdc.gov/std/treatment/2006/clinic Respiratory Tract Infection/Antibiotic Use/Community Acquired Pneumonia/Other:
Principles of appropriate antibiotic use for
CIPRO tabs
treatment of nonspecific upper respiratory tract
infection in adults are available at: http://www.cdc.gov/drugresistance/communi Antiretroviral Combinations Penicillins ty/healthcare_provider.htm
Practice guidelines and statements developed
ampicillin dicloxacillin http://www.idsociety.org penicillin VK ANTIBACTERIALS Cephalosporins AUGMENTIN Chemokine Receptor Antagonists First Generation AUGMENTIN ES-600 AUGMENTIN XR Protease Inhibitors REBETOL caps Fusion Inhibitors Herpes Agents Integrase Inhibitors Non-nucleoside Reverse Transcriptase Influenza Agents Inhibitors ANTITUBERCULAR AGENTS amantadine isoniazid pyrazinamide MYAMBUTOL FLUMADINE Nucleoside Reverse Transcriptase MISCELLANEOUS Inhibitors ANTIVIRALS Cytomegalovirus Agents mebendazole trimethoprim ganciclovir RETROVIR Hepatitis Agents Nucleotide Reverse Transcriptase MACROBID Inhibitors MACRODANTIN ANTINEOPLASTIC AGENTS
Clinical practice guidelines in oncology are
available at: http://www.nccn.org http://www.asco.org ALKYLATING AGENTS Antiestrogens KINASE INHIBITORS cyclophosphamide tamoxifen Aromatase Inhibitors ANTIMETABOLITES TOPOISOMERASE INHIBITORS Luteinizing Hormone-releasing Hormone (LHRH) Agonists MISCELLANEOUS PURINETHOL HORMONAL ANTINEOPLASTIC VESANOID Antiandrogens Progestins flutamide HYDREA VEPESID CARDIOVASCULAR
Guidelines for the evaluation and management
Committee on Prevention, Detection, Evaluation
http://www.nhlbi.nih.gov/guidelines/hyperten http://www.acc.org
Guidelines for the use of angiotensin II receptor
PRAVACHOL http://www.americanheart.org
antagonists in various patient populations are
http://www.hfsa.org
available at: http://www.diabetes.org ACE INHIBITORS http://www.nhlbi.nih.gov/guidelines/hyperten Niacins/Combinations
Guidelines for the use of ACE inhibitors are
http://www.acc.org
ATACAND * http://www.americanheart.org http://www.diabetes.org http://www.nhlbi.nih.gov/guidelines/hyperten BETA-BLOCKERS
Guidelines for the use of beta-blockers and
beta-blocker combinations in various patient
ACCUPRIL http://www.acc.org http://www.nhlbi.nih.gov/guidelines/hyperten LOTENSIN pindolol MONOPRIL
* Atacand should be reserved for patients who
meet CHARM (Candesartan in Heart Failure -
ACE INHIBITOR/CALCIUM CHANNEL BLOCKER ANTIARRHYTHMICS COMBINATIONS
Guidelines for the use of antiarrhythmics and
INDERAL LA LOPRESSOR http://www.acc.org TENORMIN TRANDATE mexiletine ACE INHIBITOR/DIURETIC COMBINATIONS BETA-BLOCKER/DIURETIC COMBINATIONS ACCURETIC BETAPACE
Guidelines for the use of beta-blockers and
CAPOZIDE BETAPACE AF LOTENSIN HCT CORDARONE MONOPRIL-HCT http://www.acc.org VASERETIC NORPACE CR http://www.nhlbi.nih.gov/guidelines/hyperten ZESTORETIC ADRENOLYTICS, CENTRAL TAMBOCOR LOPRESSOR HCT TENORETIC CATAPRES ANTILIPEMICS
Guidelines for the use of antilipemics in various
CALCIUM CHANNEL BLOCKERS http://www.nhlbi.nih.gov Dihydropyridines ALDOSTERONE RECEPTOR Bile Acid Resins ANTAGONISTS ADALAT CC ALDACTONE COLESTID PROCARDIA XL QUESTRAN/QUESTRAN LIGHT ALPHA BLOCKERS Nondihydropyridines Cholesterol Absorption Inhibitors
Guidelines for the use of alpha blockers in
various patient populations are available at:
http://www.nhlbi.nih.gov/guidelines/hyperten CARDIZEM CD Fibrates CARDURA HYTRIN CALCIUM CHANNEL BLOCKER/ANTILIPEMIC ANGIOTENSIN II RECEPTOR COMBINATIONS ANTAGONIST/CALCIUM CHANNEL BLOCKER COMBINATIONS HMG-CoA Reductase Inhibitors DIGITALIS GLYCOSIDES digoxin ped elixir ANGIOTENSIN II RECEPTOR ANTAGONISTS/DIURETIC COMBINATIONS hydrochlorothiazide NITRATE/VASODILATOR DIRECT RENIN INHIBITORS indapamide COMBINATIONS ZAROXOLYN DIRECT RENIN INHIBITOR Diuretic Combinations PULMONARY ARTERIAL COMBINATIONS amiloride/hydrochlorothiazide HYPERTENSION Endothelin Receptor Antagonists ALDACTAZIDE DIURETICS Carbonic Anhydrase Inhibitors NITRATES Phosphodiesterase Inhibitors acetazolamide methazolamide isosorbide dinitrate ext-rel tabs DIAMOX SEQUELS Prostaglandin Vasodilators Loop Diuretics Sublingual MISCELLANEOUS NITROSTAT Potassium-sparing Diuretics hydralazine Transdermal methyldopa amiloride nitroglycerin transdermal Thiazide and Thiazide-like Diuretics NITRO-DUR PROAMATINE chlorthalidone CENTRAL NERVOUS SYSTEM
Practice guidelines for psychiatric disorders are
DILANTIN
available at: http://www.psych.org ANTIANXIETY MYSOLINE Benzodiazepines TEGRETOL
TEGRETOL-XR ZARONTIN Serotonin Norepinephrine Reuptake ZONEGRAN KLONOPIN Inhibitors (SNRIs)* *Indicates the proposed mechanism of action, ANTIDEMENTIA
based on the American Psychiatric Association
Summary of Treatment Recommendations. Miscellaneous fluvoxamine RAZADYNE RAZADYNE ER ANAFRANIL BUSPAR Tricyclic Antidepressants (TCAs) ANTIDEPRESSANTS ANTICONVULSANTS
Although these agents are primarily indicated
amitriptyline
Practice guidelines for the treatment of epilepsy
approved for other indications, including bipolar
are available at: http://www.aan.com
disorder, obsessive-compulsive disorder, panic
NORPRAMIN
disorder, and premenstrual dysphoric disorder. phenobarbital
Guidelines for the evaluation and management
TOFRANIL DEPAKOTE
available at: http://www.psych.org Miscellaneous Agents DEPAKOTE ER Monoamine Oxidase Inhibitors (MAOIs) trazodone LAMICTAL WELLBUTRIN WELLBUTRIN SR NEURONTIN Selective Serotonin Reuptake Inhibitors WELLBUTRIN XL TRILEPTAL ANTIPARKINSONIAN AGENTS
Practice guidelines for the diagnosis and
treatment of Parkinson's disease are available
DEPAKENE
at: http://www.aan.com amantadine LITHOBID benztropine trihexyphenidyl MULTIPLE SCLEROSIS AGENTS
Practice guidelines for multiple sclerosis are
available at: http://www.aan.com DEXEDRINE DEXEDRINE SPANSULE METADATE ER MUSCULOSKELETAL THERAPY
APOKYN ELDEPRYL HYPNOTICS
Practice parameters for the treatment of sleep
baclofen PARLODEL orphenadrine/aspirin/caffeine http://www.aasmnet.org SINEMET CR Benzodiazepines DANTRIUM FLEXERIL ANTIPSYCHOTICS PARAFON FORTE DSC Atypicals RESTORIL ROBAXIN SKELAXIN Nonbenzodiazepines ZANAFLEX tabs MYASTHENIA GRAVIS RISPERDAL MESTINON MIGRAINE NARCOLEPSY/CATAPLEXY
Guidelines for prevention and management of
CLOZARIL http://www.aan.com Miscellaneous Ergotamine Derivatives chlorpromazine CAFERGOT PSYCHOTHERAPEUTIC- fluphenazine MISCELLANEOUS haloperidol D.H.E. 45 Alcohol Deterrents perphenazine thioridazine trifluoperazine Selective Serotonin Agonists Narcotic Antagonists ATTENTION DEFICIT HYPERACTIVITY DISORDER
Guidelines for the evaluation and management
Smoking Deterrents
of attention deficit disorder are available at:
http://www.aacap.org http://www.aap.org nicotine transdermal MOOD STABILIZERS lithium carbonate lithium carbonate ext-rel tabs 450 mg ENDOCRINE AND METABOLIC ANDROGENS METAGLIP
Clinical practice guidelines for the treatment of
Dipeptidyl Peptidase-4 (DPP-4) http://www.aace.com Amylin Analogs Inhibitors Biguanides Dipeptidyl Peptidase-4 (DPP-4) Inhibitor/Biguanide Combinations ANTIDIABETICS GLUCOPHAGE
Guidelines of treatment and management of
GLUCOPHAGE XR Incretin Mimetic Agents http://www.diabetes.org Biguanide/Sulfonylurea Combinations Alpha-glucosidase Inhibitors Insulins
Guidelines of treatment and management of
http://www.aace.com CYCLESSA http://www.nof.org ORTHO TRI-CYCLEN ORTHO-NOVUM 7/7/7
HUMULIN 50/50 OTC TRI-LEVLEN
HUMULIN 70/30 OTC TRI-NORINYL
HUMULIN N OTC
HUMULIN R OTC Extended Cycle Calcitonins
NOVOLIN 70/30 OTC
NOVOLIN N OTC calcitonin-salmon - Fortical SEASONALE
NOVOLIN R OTC MIACALCIN Continuous Parathyroid Hormones Insulin Sensitizers Progestin Only CONTRACEPTIVES NOR-QD ORTHO MICRONOR Insulin Sensitizer/Biguanide Combinations Monophasic Emergency Contraception 20 mcg Estrogen Insulin Sensitizer/Sulfonylurea Injectable Combinations LOESTRIN 1/20 DEPO-PROVERA LOESTRIN FE 1/20 Progestin Intrauterine Device 30 mcg Estrogen Meglitinides levonorgestrel/EE 0.15/30 - Levora norgestrel/EE 0.3/30 - Low-Ogestrel Transdermal Sulfonylureas LOESTRIN 1.5/30 LOESTRIN FE 1.5/30 GLUCOTROL ORTHO-CEPT GLUCOTROL XL Supplies 35 mcg Estrogen ENDOMETRIOSIS
ACCU-CHEK kits and test strips OTC ethynodiol diacetate/EE 1/35 - Zovia
ASCENSIA kits and test strips OTC
BD insulin syringes and needles OTC
LANCETS OTC BREVICON
ONETOUCH kits and test strips OTC ESTROGENS ANTIOBESITY NORINYL 1+35
Guidelines of treatment and management of
Guidelines of treatment and management of
ORTHO-CYCLEN
hormone therapy and menopause are available
obesity are available at: http://www.aace.com ORTHO-NOVUM 1/35
at: http://www.menopause.org http://www.nhlbi.nih.gov/guidelines/obesity/ ob_home.htm 50 mcg Estrogen Monoamine Reuptake Inhibitors ethynodiol diacetate/EE 1/50 - Zovia Fat Absorption Decreasing Agents NORINYL 1+50 ORTHO-NOVUM 1/50 Transdermal CALCIUM RECEPTOR Biphasic ANTAGONISTS MIRCETTE Triphasic CALCIUM REGULATORS Bisphosphonates levonorgestrel/EE - Trivora prednisone PROGESTINS PEDIAPRED ESTROGEN/PROGESTINS AYGESTIN GLUCOSE ELEVATING AGENTS estradiol/norethindrone SELECTIVE ESTROGEN RECEPTOR MODULATORS HUMAN GROWTH HORMONES THYROID AGENTS
available at: http://www.aace.com Antithyroid Agents Transdermal propylthiouracil
NORDITROPIN ##
NUTROPIN/NUTROPIN AQ ## TAPAZOLE
SAIZEN ## Thyroid Supplements FERTILITY REGULATORS HYPERPARATHYROID levothyroxine TREATMENT, VITAMIN D levothyroxine - Levoxyl chorionic gonadotropin - Novarel SYNTHROID VASOPRESSINS PHENYLKETONURIA TREATMENT MISCELLANEOUS GLUCOCORTICOIDS PHOSPHATE BINDER AGENTS CARNITOR DOSTINEX dexamethasone fludrocortisone GASTROINTESTINAL
Guidelines for the treatment and management
of various gastrointestinal diseases/conditions
AZULFIDINE
are available at: http://www.acg.gi.org AZULFIDINE EN-TABS http://www.gastro.org LEVSINEX ANTIDIARRHEALS Rectal Agents loperamide CHOLELITHOLYTICS hydrocortisone enema ANTIEMETICS ACTIGALL prochlorperazine H2-RECEPTOR ANTAGONISTS promethazine LAXATIVES lactulose ANTIVERT INFLAMMATORY BOWEL DISEASE Injectable Agents NULYTELY TIGAN caps Oral Agents ANTISPASMODICS PANCREATIC ENZYMES chlordiazepoxide/clidinium PROCTOCREAM-HC 2.5% PRILOSEC ULCER THERAPY COMBINATIONS PROSTAGLANDINS SALIVA STIMULANTS PROTON PUMP INHIBITORS MISCELLANEOUS pantoprazole delayed-rel STEROIDS, RECTAL GENITOURINARY BENIGN PROSTATIC VAGINAL ANTI-INFECTIVES HYPERPLASIA Phosphodiesterase Inhibitors METROGEL-VAGINAL
available at: http://www.auanet.org/guidelines URINARY ANTISPASMODICS TERAZOL 3 TERAZOL 7 MISCELLANEOUS ERECTILE DYSFUNCTION
Guidelines for the management of erectile
UROCIT-K http://www.auanet.org/guidelines Alprostadil Agents PYRIDIUM DITROPAN URECHOLINE DITROPAN XL HEMATOLOGIC
Guidelines of treatment and management of
HEMATOPOIETIC GROWTH PLATELET AGGREGATION http://www.hemophilia.org
Guidelines for the management of neutropenia
INHIBITORS ANTICOAGULANTS
are available at: http://www.asco.org Injectable
associated with chronic kidney disease are
http://www.kidney.org/professionals/kdoqi/g PERSANTINE uidelines.cfm PLATELET SYNTHESIS INHIBITORS COUMADIN Synthetic Heparinoid-like Agents PAROXYSMAL NOCTURNAL MISCELLANEOUS HEMOGLOBINURIA (PNH) AGENTS IMMUNOLOGIC AGENTS DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) PLAQUENIL
Guidelines for the management of rheumatic
IMMUNOSUPPRESSANTS IMMUNOMODULATORS Antimetabolites http://www.rheumatology.org methotrexate http://www.cdc.gov/ncidod/diseases/hepatiti s/index.htm
Guidelines for the management of hepatitis are
available at: http://www.aasld.org Interferons Calcineurin Inhibitors SANDIMMUNE Rapamycin Derivatives NUTRITIONAL/SUPPLEMENTS
Guidelines for recommended dietary intakes for
VITAFOL-PN http://www.nal.usda.gov/fnic/etext/000105.ht Miscellaneous Prenatal Vitamins ELECTROLYTES cyanocobalamin inj Potassium vitamin ADC/fluoride drops vitamin ADC/fluoride/iron drops potassium chloride liquid CITRANATAL RX LURIDE LOZI-TABS VITAMINS AND MINERALS POLY-VI-FLOR ROCALTROL Folic Acid Agents folic acid VITAFOL-OB RESPIRATORY
Guidelines to the management, prevention, or
ANTIHISTAMINE/DECONGESTANT
treatment of COPD and asthma are available at:
COMBINATIONS http://www.aaaai.org http://www.nhlbi.nih.gov http://www.goldcopd.com brompheniramine/pseudoephedrine 4 http://www.ginasthma.com mg/45 mg per 5 mL brompheniramine/pseudoephedrine ext- PROVENTIL
allergyrelated conditions are available at:
rel 12 mg/120 mg PROVENTIL soln http://www.aaaai.org brompheniramine/pseudoephedrine ext- rel 6 mg/60 mg ANAPHYLAXIS TREATMENT Long Acting DECONAMINE SR ANTICHOLINERGICS Oral Agents
ZYRTEC-D 12 Hour OTC ipratropium soln ANTITUSSIVES albuterol VOSPIRE ER TESSALON BRETHINE ANTITUSSIVE COMBINATIONS Narcotic ANTICHOLINERGIC/BETA CYSTIC FIBROSIS AGONIST COMBINATIONS codeine/chlorpheniramine/pseudoephe codeine/guaifenesin liquid codeine/guaifenesin/pseudoephedrine LEUKOTRIENE RECEPTOR codeine/promethazine ANTAGONISTS ANTIHISTAMINES, LOW SEDATING PROMETHAZINE VC w/CODEINE
XYZAL ZYRTEC OTC MAST CELL STABILIZERS Non-narcotic ANTIHISTAMINES, NONSEDATING dextromethorphan/brompheniramine/ps eudoephedrine INTAL soln dextromethorphan/promethazine ANTIHISTAMINES, SEDATING NASAL ANTIHISTAMINES clemastine 2.68 mg BETA AGONISTS cyproheptadine Inhalants hydroxyzine HCl Short Acting NASAL STEROIDS flunisolide spray XANTHINES theophylline ext-rel tabs STEROID INHALANTS MISCELLANEOUS STEROID/BETA AGONIST ATROVENT spray COMBINATIONS DERMATOLOGY Antipsoriatics
Guidelines for care of dermatological conditions
Very High Potency http://www.aad.org/professionals/guidelines/ diflorasone diacetate oint 0.05%
Guidelines for the care and treatment of acne
vulgaris are available at: http://www.aad.org DIPROLENE gel, oint Oral ACCUTANE Antiseborrheics TEMOVATE ULTRAVATE Topical NIZORAL SHAMPOO erythromycin soln Emollients sulfacetamide/sulfur crm, gel, lotion, Corticosteroids
Guidelines of care for the use of topical
LAC-HYDRIN tretinoin (generic of AVITA) http://www.aad.org Immunomodulators Low Potency
Guidelines for the treatment of atopic dermatitis
are available at: http://www.aad.org fluocinolone acetonide soln 0.01% hydrocortisone lotion 1% ACLOVATE Local Analgesics BENZAC AC BENZAMYCIN CLEOCIN T Medium Potency Local Anesthetic betamethasone valerate crm, lotion, oint 0.1% desoximetasone crm 0.05% Actinic Keratosis fluocinolone acetonide crm, oint 0.025% metronidazole gel 0.75% CUTIVATE Antibiotics KENALOG 0.025% gentamicin KENALOG 0.1% METROCREAM BACTROBAN METROLOTION WESTCORT SILVADENE High Potency Scabicides and Pediculicides Antifungals betamethasone dipropionate crm, clotrimazole lotion, oint 0.05% econazole diflorasone diacetate crm 0.05% DIPROLENE AF DIPROLENE lotion Miscellaneous Skin and Mucous KENALOG 0.5% Membrane MYCOSTATIN PSORCON E crm CONDYLOX
PSORCON E oint TOPICORT Immunomodulators MOUTH/THROAT/DENTAL AGENTS CORTISPORIN Anesthetics - Topical Oral MAXITROL XYLOCAINE VISCOUS Anti-inflammatories Parasympathomimetics Nonsteroidal Steroids - Mouth/Throat ISOPTO CARPINE KENALOG IN ORABASE Prostaglandins OPHTHALMIC VOLTAREN
Preferred Practice Pattern Guidelines for the
Steroidal http://www.aao.org/education/guidelines/ppp /index.cfm dexamethasone sodium phosphate Sympathomimetics Antiallergics prednisolone phosphate 1% brimonidine 0.2% Sympathomimetic/Beta-blocker PRED FORTE Combinations Antivirals ZADITOR OTC VIROPTIC OTIC Clinical practice guidelines for the treatment of Anti-infectives Beta-blockers Nonselective http://www.aap.org bacitracin Anti-infectives erythromycin gentamicin acetic acid polymyxin B/bacitracin OPTIPRANOLOL FLOXIN OTIC TIMOPTIC TIMOPTIC-XE DOMEBORO OTIC Selective Anti-infective/Anti-inflammatory BLEPH-10 Combinations NEOSPORIN acetic acid/hydrocortisone Carbonic Anhydrase Inhibitors POLYTRIM Topical Anti-infective/Anti-inflammatory Combinations CORTISPORIN OTIC sulfacetamide/prednisolone Miscellaneous Carbonic Anhydrase Inhibitor/Beta- phosphate10%/0.25% blocker Combinations
opinión | 52 Escribe: Dr. Matías Sanz Navamuel Los actos de autoprotección ejemplo: no recibir transfusiones de ha sido declarada en numerosos fallos. *La conveniencia de la escritura pública En el año 2005 dos casos de pacientes condición humana. es indiscutible, debiéndose contar entre terminales conmovieron a la sociedad: el Como se ha visto, bioética y derecho sus vent
EFFECTIVENESS RESEARCH LEADING TO APPROVALS FOR CONTROLLING MORTALITY IN COOLWATER AND WARMWATER FINFISH DUE TO AEROMONAD INFECTIONS WITH TERRAMYCIN 200 FOR FISH® (OXYTETRACYCLINE DIHYDRATE) AND AQUAFLOR® (FLORFENICOL) Chairperson: Mark P. Gaikowski, U.S. Geological Survey Upper Midwest Industry Advisory Council Liaison: Funding Request: Duration: 2 Years